DSIP Peptide

DSIP (Delta Sleep-Inducing Peptide) is a naturally occurring nonapeptide (Trp-Ala-Gly-Gly-Asp-Ala-Ser-Gly-Glu, WAGGDASGE) with MW 848.81 g/mol and CAS 62568-57-4. First isolated in 1974 from the cerebral venous blood of rabbits during induced sleep (Schoenenberger-Monnier group, Basel), DSIP promotes delta wave (Stage 3/4) sleep — the deepest, most restorative phase of the sleep cycle.

DSIP crosses the blood-brain barrier and acts on multiple neuroendocrine systems: it modulates GABA and glutamate signaling, suppresses cortisol and ACTH, enhances LH release, and regulates somatostatin/GH secretion patterns. Its research profile spans sleep medicine, stress physiology, circadian biology, and endocrine regulation.

Delta Wave Enhancement: DSIP promotes EEG delta wave activity (0.5-4 Hz), increasing the duration and depth of Stage 3/4 slow-wave sleep without suppressing REM sleep. The mechanism involves modulation of GABAergic interneurons in the ventrolateral preoptic area (VLPO).

Cortisol/ACTH Suppression: DSIP reduces ACTH and cortisol secretion, potentially explaining stress-buffering effects. It normalizes the HPA axis response in chronic stress models.

Somatotropin Modulation: DSIP enhances the nocturnal GH pulse amplitude during delta sleep, connecting sleep architecture to growth hormone research.

Reconstitution solvent selection. DSIP is a hydrophilic, highly water-soluble nonapeptide owing to its three glycines, hydroxyl-bearing serine, and acidic Asp/Glu residues, with a calculated isoelectric point near pH 3.5. It readily dissolves in bacteriostatic water (0.9% benzyl alcohol) or sterile water for injection without requiring co-solvents, acidification, or sonication. For multi-aliquot research workflows, bacteriostatic water is generally preferred because the benzyl alcohol preservative suppresses microbial growth during the working period; sterile water is appropriate when a single-use aliquot is anticipated or when preservative-free conditions are required for downstream analytical work.

Reconstitution procedure. Prior to reconstitution, allow the lyophilized vial to reach room temperature inside its sealed packaging to prevent condensation onto the cake. Wipe the rubber stopper with 70% isopropanol and allow to dry. Using a sterile syringe, draw the desired volume of diluent and inject slowly down the inner wall of the vial—never directly onto the lyophilized peptide cake—to minimize foaming and shear-induced denaturation. Gently swirl the vial; do not shake or vortex aggressively, as mechanical agitation introduces air-water interfacial stress that can promote aggregation in linear peptides. Complete dissolution typically occurs within 30–60 seconds yielding a clear, colorless solution.

Concentration calculations. Standard preparations are summarized below:

Researchers should select concentrations compatible with the precision of their measuring instruments and the volumetric requirements of their experimental model. Lower concentrations may be preferable for in vitro receptor binding studies, while higher concentrations reduce diluent volume in murine pharmacokinetic experiments.

Photoprotection during handling. The N-terminal tryptophan residue (Trp¹) confers significant UV sensitivity. Indole-ring photo-oxidation can produce N-formylkynurenine and kynurenine, structurally altering the peptide and confounding research results. Reconstituted vials should be wrapped in aluminum foil, stored in amber glassware, or kept inside opaque containers throughout the experimental period. When transferring solutions for analytical work, reduce ambient lighting where practical, and avoid prolonged exposure to laboratory UV transilluminators or unfiltered fluorescent lighting.

Aliquoting strategy. For studies extending beyond two weeks, prepare working aliquots immediately after reconstitution into low-binding polypropylene tubes (peptide adsorption to glass and standard polystyrene can be significant for sub-milligram quantities). Single freeze-thaw events at -20°C or -80°C are generally tolerated by DSIP, but repeated cycling should be avoided. Document reconstitution date, lot number, diluent type, and storage conditions on each aliquot to support reproducibility.

Sterile technique and safety. All reconstitution should occur within a laminar flow hood or equivalent clean environment using sterile, single-use syringes and filter needles where appropriate. Standard laboratory PPE—nitrile gloves, lab coat, and safety eyewear—is required. This product is for in vitro and preclinical research only; it is not intended for administration to humans or animals outside of approved research protocols.

Lyophilized powder storage. DSIP (Trp-Ala-Gly-Gly-Asp-Ala-Ser-Gly-Glu, MW 848.8 Da) in its solid lyophilized form is highly stable when stored desiccated at -20°C, with a documented shelf life of approximately 24 months under sealed, moisture-free conditions. For long-term archival storage exceeding two years, -80°C in an airtight container with desiccant (silica gel) is preferred to suppress residual hydrolytic activity and to limit any slow oxidation of the tryptophan side chain. Repeated removal of the vial from cold storage should be avoided; allow vials to equilibrate to room temperature inside a sealed container before opening to prevent atmospheric moisture from condensing onto the lyophilized cake, which can accelerate peptide bond hydrolysis and dimerization.

Reconstituted solution stability. Once reconstituted in bacteriostatic water (0.9% benzyl alcohol) or sterile water, DSIP solutions should be refrigerated at 2–8°C and used within approximately 14 days for research applications requiring high peptide integrity. Stability studies of related small linear peptides indicate that aqueous solutions stored at neutral pH and refrigerated temperatures retain >90% peptide content over two weeks, though degradation accelerates significantly above 25°C. Freezing reconstituted DSIP is generally discouraged because freeze-thaw cycles promote aggregation and partial precipitation, particularly at higher concentrations.

Photosensitivity considerations. DSIP is unusual among short peptides in containing an N-terminal tryptophan residue. Tryptophan's indole ring absorbs UV light strongly around 280 nm and is susceptible to photo-oxidation, generating N-formylkynurenine and kynurenine derivatives that fundamentally alter the molecule's identity and potential bioactivity. Vials—whether lyophilized or reconstituted—should therefore be stored in amber glass, wrapped in foil, or kept inside opaque secondary containers. Laboratory bench work involving DSIP solutions should minimize ambient fluorescent and UV exposure; transferring under reduced light conditions is recommended for sensitive analytical workflows.

Oxidation and pH sensitivity. Beyond photochemistry, tryptophan is also vulnerable to oxidation by reactive oxygen species, peroxides, and trace transition metals (Fe³⁺, Cu²⁺). Use of high-purity solvents and avoidance of metallic contamination during reconstitution helps preserve integrity. The aspartate (Asp⁵) and glutamate (Glu⁹) residues make DSIP modestly susceptible to acid-catalyzed isomerization and amide cleavage; storage at strongly acidic or alkaline pH should be avoided. The peptide is most stable in the slightly acidic to neutral pH window (approximately pH 5–7).

Quality monitoring. Researchers conducting longitudinal studies are advised to periodically verify peptide integrity by HPLC and mass spectrometry, monitoring for the appearance of oxidation products (+16 Da, +32 Da mass shifts indicating tryptophan oxidation) and hydrolytic fragments. Visible cloudiness, discoloration (yellowing), or particulates in reconstituted solution indicate degradation or contamination, and such material should not be used for quantitative research. For laboratory research use only — not for human or veterinary administration.